Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKinsey
McKesson
Argus Health
Daiichi Sankyo
Julphar
Merck
Baxter
UBS

Generated: April 22, 2018

DrugPatentWatch Database Preview

OXAZEPAM Drug Profile

« Back to Dashboard

When do Oxazepam patents expire, and what generic alternatives are available?

Oxazepam is a drug marketed by Actavis Elizabeth, Am Therap, Anda Repository, Ivax Sub Teva Pharms, Mylan, Sandoz, Watson Labs, Watson Labs Teva, Parke Davis, and Sun Pharm Industries. and is included in twenty NDAs.

The generic ingredient in OXAZEPAM is oxazepam. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the oxazepam profile page.
Drug patent expirations by year for OXAZEPAM
Pharmacology for OXAZEPAM
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for OXAZEPAM
Synonyms for OXAZEPAM
(.+/-.)-Oxazepam
(+-)-7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one
(+-)-Oxazepam
(RS)-Oxazepam
1,3-Dihydro-7-chloro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one
1,3-Dihydro-7-chloro-3-hydroxy-5-phenyl-3H-1,4-benzodiazepin-2-one
2H-1, 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-
2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-
2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-, (+-)-
2H-1,4-Benzodiazepin-2-one,7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-
3-hydroxy-1,3-dihydro-7-chloro-5-phenyl-2H-1,4-benzodiazepin-2-one
3-hydroxy-5-phenyl-7-chloro-2,3-dihydro-1H-1,4-benzodiazepin-2-one
3-Hydroxynordiazepam
35295-88-6
604-75-1
604O751
61036-43-9
7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-1,4 [2Hl-benzodiazepin-2-one
7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-1,4(2H)-benzodiazepin-2-one
7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one
7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepine-2-one
7-Chloro-1,4-benzodiazepine-2-one
7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
7-Chloro-3-hydroxy-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-CHLORO-3-HYDROXY-5-PHENYL-1,3-DIHYDRO-2H-BENZO[E][1,4]DIAZEPIN-2-ONE
7-Chloro-3-hydroxy-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one
7-Chloro-3-hydroxy-5-phenyl-1,4-benzodiazepin-2-one
7-chloro-3-hydroxy-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
7-chloro-5-phenyl-3H-1,4-benzodiazepine-2,3-diol
Abboxampam
Abboxapam
AC1L1IKD
ADIMAYPTOBDMTL-UHFFFAOYSA-
ADIMAYPTOBDMTL-UHFFFAOYSA-N
Adumbran
Alepam
Alepam (TN)
AN-16712
Ansioxacepam
Anxiolit
Anxiolit retard
API0003709
Aplakil
Apo-astress
Astress
Azutranguil
Azutranquil
BDBM85031
Bonare
C07359
CAS_604-75-1
CAS-604-75-1
CB 8092
CCRIS 488
CHEBI:7823
CHEMBL568
D00464
D09LDR
DB00842
DEA No. 2835
DF2371850
DivK1c_000986
Drimuel
Droxacepam
DSSTox_CID_1087
DSSTox_GSID_21087
DSSTox_RID_75934
DTXSID1021087
Durazepam
EINECS 210-076-9
FT-0673333
GTPL7253
HE004327
HE359391
HE376320
Hi-Long
Hilong
HMS503E13
HSDB 3140
IDI1_000986
InChI=1/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19)
Isodin
KBio1_000986
Lederpam
Limbial
LS-34236
LS-44
Medopam (TN)
MFCD00057903
Murelax
Murelax (TN)
N-Desmethyltemazepam
NCGC00159323-02
NCGC00159323-03
NCGC00159323-04
NCGC00257352-01
NCGC00258254-01
Nesontil
NINDS_000986
Noctazepam
Noripam (TN)
Nortemazepam
Nozepam
NSC 169448
NSC_4616
NSC-169448
NSC169448
O5254_SIGMA
Oprea1_501459
Ossazepam
Ossazepam [DCIT]
Ox-Pam (TN)
Oxa-puren
Oxanid
Oxazepam (JAN/USP/INN)
Oxazepam [USAN:INN:BAN:JAN]
Oxazepam 0.1 mg/ml in Methanol
Oxazepam 1.0 mg/ml in Methanol
Oxazepam for peak identification, European Pharmacopoeia (EP) Reference Standard
Oxazepam solution, 1 mg/mL in methanol, ampule of 1 mL, certified reference material
Oxazepam solution, drug standard, 1.0 mg/mL in methanol
Oxazepam, European Pharmacopoeia (EP) Reference Standard
Oxazepamum
Oxazepamum [INN-Latin]
Oxazipam
Oxozepam
p acienx
Pacienx
Praxiten
Propax
Psicopax
Psiquiwas
Purata (TN)
QUEN
Quilibrex
Ro 5-6789
Rondar
SCHEMBL27435
Sedigoa
Serax
Serax (TN)
Serenal
Serenid
Serenid-D
Serepax
Serepax (TN)
Seresta
Serpax
Sigacalm
Sobril
SR-01000942251
SR-01000942251-1
Tacepam
Tarchomin
Tazepam
Tox21_111572
Tox21_112819
Tox21_200700
Tox21_303501
tranquo-buscopan- wirkstoff
Tranquo-buscopan-wirkstoff
Uskan
Vaben
WLN: T67 GMV JN IHJ CG IQ KR
Wy 3498
WY-3498
Wy-3498 stic
Z 10 tr
Z10-Tr
Zaxopam

US Patents and Regulatory Information for OXAZEPAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth OXAZEPAM oxazepam CAPSULE;ORAL 072253-002 Apr 14, 1988 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz OXAZEPAM oxazepam CAPSULE;ORAL 071814-001 Apr 19, 1988 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs OXAZEPAM oxazepam TABLET;ORAL 071494-001 Apr 21, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Anda Repository OXAZEPAM oxazepam CAPSULE;ORAL 071026-002 Aug 10, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Argus Health
AstraZeneca
Chinese Patent Office
Cerilliant
US Department of Justice
Medtronic
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.